Search

Astrazeneca Pharma India

Sector: Healthcare | Industry: Drugs & Pharma
R 2,278.35 -20.90  | -0.91% 37.62% 81.79 5,689.63
NSE Price: Oct 18, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 18, 15:59 2,278.35 -20.90 -0.91% 2,308.75 2,299.25 6,292 2,260.25 - 2,344.00
BSE Oct 18, 2019 2,275.85 -23.65 -1.03% 2,328.60 2,299.50 670 2,265.00 - 2,331.25
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 19,271 P/B: 17.77 NSE Code: ASTRAZEN
52-Week Range: R 1,306.05 - 2,397.70 Dividend Yield: 0.00% BSE Code: 506820
TTM EPS: R 27.83 Book Value: R 128.09 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Astrazeneca Pharma India 56.95 10.36 16.81 37.50 33.06 21.72 9.71
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of NSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 27.55 8.91 8.97
Net Profit 110.15 117.95 155.55
EPS 110.15 117.95 155.54
Book Value 21.99 24.17 11.72
Average
Operating Margin 12.03 10.57 6.95
Net Margin 7.31 5.12 2.46
Return on Networth 20.03 13.93 6.46
Return on Investment 26.53 21.31 10.95
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 7.49 26.71 7.49
Operating Profit 211.35 203.50 211.35
Net Profit 119.00 236.54 119.00
EPS 119.00 236.54 119.00
TTM
Revenue 5.92 27.52 5.92
Operating Profit 29.52 87.88 29.52
Net Profit 27.78 161.05 27.78
EPS 27.78 161.05 27.78
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Astrazeneca Pharma India 5,689.63 771.42 69.56 8.84 20.03 17.77 81.79
Eris Lifesciences 5,793.71 1,005.70 303.64 29.29 28.96 4.70 19.08
Laurus Labs 3,367.27 2,303.47 92.30 3.98 6.19 2.14 36.48
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
May 28, 2013 AstraZeneca Pharmaceuticals AB Sweden  Sell - 3,749,950 668.60 25,072.17
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
ICICI Prudential Mutual Fund 1.909 2.523 3.095 4.186 4.312
Nippon India Mutual Fund 1.131 1.131 1.131 1.131 1.131
IDBI Mutual Fund 0.009 0.004 - - -
Motilal Oswal Mutual Fund 0.001 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Astrazeneca Pharma India Ltd.

Address: Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, Bengaluru, Karnataka - 560045

Email: [email protected]

Website: www.astrazenecaindia.com

Registrar & Transfer Agent: Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

Address: 30, Ramana Residency, 4th Cross, Sampige Road, Malleswaram, Bangalore 560003, 30, Ramana Residency, 4th Cross, Sampige Road, Malleswaram | Phone: 91-080-23460815 to 818 | Fax: 91-080 23460819

Email: [email protected], [email protected]

Essential checks
Altman Z-Score
13.61
Piotroski F-Score
9
Modified C-Score
2
5-Years Price to Earnings
81.79
5-Years Price to Book
17.77
Earnings Yield
EBIT / Enterprise value
1.77%
PEG
Price / Earnings to growth ratio
2.01
Related Stocks
  Current Price   Chng %
Caplin Point Laboratories R396.85 +0.61%
Dishman Carbogen Amcis R155.20 -0.23%
Eris Lifesciences R422.60 +1.57%
FDC R160.90 -0.28%
JB Chemicals & Pharma R366.55 +2.03%
Laurus Labs R316.20 +1.92%
Strides Pharma Science R353.85 0.00%
Sun Pharma Adv. Research R132.50 +1.38%
Suven Life Sciences R280.55 +5.95%
Wockhardt R266.45 +2.80%
As on Oct 18, 15:59